Sandy Liebhard

Sandy A. Liebhard, a founding partner at Bernstein Liebhard LLP, has successfully represented plaintiffs in complex litigations for more than 20 years. As dedicated consumer advocates, Mr. Liebhard and his fellow attorneys have taken on some of the largest corporate interest in the nation in cases involving dangerous pharmaceuticals, faulty medical devices and defective consumer products. As an author for RXInuryHelp.com, Mr. Liebhard has written extensively on the litigation involving proton pump inhibitors (Nexium, Prilosec, PrevAcid, etc.) and kidney injuries; Risperdal and gynecomastia; the Bair Hugger forced air warming blanket; talcum powder and ovarian cancer; transvaginal mesh; power morcellators; defective hip implants; and more.

Mr. Liebhard is a 1988 graduate of Brooklyn Law School. He is admitted to the Bar of the State of New York, as well as the United States District Courts for the Southern and Eastern Districts of New York.


Johnson & Johnson Wants Judge Removed from Upcoming DePuy Pinnacle Hip Lawsuit Trial

Johnson & Johnson is attempting to prevent a federal judge from presiding over the next bellwether trial of a DePuy Pinnacle hip lawsuit. In a petition recently filed with the 5th Circuit Court of Appeals, the company asserted that U.S. … Continue reading

Johnson & Johnson, Ethicon Appeal Decision Granting Transvaginal Mesh Lawsuit Plaintiff New Damages Hearing

Johnson & Johnson and Ethicon, Inc. have appealed a decision by a Pennsylvania judge to order a new hearing on damages in a transvaginal mesh lawsuit that went to trial earlier this summer. The case, Adkins v. Ethicon, was decided … Continue reading

Talcum Powder Lawsuit Verdict Pending, As Jury Deliberations Begin in First California Ovarian Cancer Trial

A California jury has begun deliberating in the state’s first products liability trial over the alleged link between Johnson & Johnson’s talcum powders and ovarian cancer. According to Law360.com, the parties delivered their closing arguments Wednesday, with the plaintiff’s attorney … Continue reading

Alabama Physiomesh Lawsuit Claims “Unreasonably Dangerous” Multi-Layer Design Led to Severe Hernia Complications

An Alabama man has filed a Physiomesh lawsuit against Ethicon, Inc., claiming he suffered severe hernia complications due to its “unreasonably dangerous” multi-layer design. Plaintiff: Physiomesh Warnings Inadequate According to his August 15th filing in the U.S. District Court, Southern … Continue reading

Cook Medical Issues Class I Zenith Alpha Endo Graft Recall Following Reports of Blood Clots, Occlusions

Cook Medical, Inc. is recalling certain Zenith Alpha thoracic endovascular grafts, following reports that blood clots and occlusions had formed inside some of the devices when they were used to treat patients with blunt traumatic aortic injury (BTAI). The U.S. … Continue reading

Homeolab USA Receives FDA Warning Letter in Connection with Raritan Teething Tablets Recall

The U.S. Food & Drug Administration (FDA) has issued a new Warning Letter to Homeolab USA, in connection with a teething tablets recall announced last year by Raritan Pharmaceuticals, Inc. “Some of your powder blend mixtures are manufactured from ingredients … Continue reading

New Nexium Side Effects Concerns, As Study Suggests Link Between Proton Pump Inhibitors, Pancreatic Cancer

A recent study is raising additional concerns about the side effects possibly linked with Nexium and other proton pump inhibitors. The research, which was presented earlier this summer at the annual Digestive Disease Week conference, suggested that proton pump inhibitors … Continue reading

Talcum Powder Ovarian Cancer Trial Continues in California, As Plaintiffs’ Pathology Expert Takes the Stand

A pathology expert called to testify in California’s first talcum powder ovarian cancer trial told a Los Angeles Superior Court jury earlier this month that talc particles had been detected in the plaintiff’s ovaries. According to Law360.com, John Godleski recently … Continue reading

Missouri Judge Dismisses Risperdal Lawsuits Filed by Out-of-State Plaintiffs

A federal judge in Missouri has dismissed 53 Risperdal lawsuits filed by out-of-states plaintiffs, after determining that the state was not an appropriate venue for the cases. According to Reuters, the order dismissing the claims was handed down on August … Continue reading

Additional Actemra Indication Being Explored, Despite Heart Attack and Other Adverse Event Reports Associated with RA Treatment

The manufacturers of Actemra are exploring yet another indication for the rheumatoid arthritis (RA) treatment, despite a recent analysis that linked the medication to thousands of adverse events, including heart attacks, strokes, pancreatitis, and death. Actemra Adverse Event Reports Actemra … Continue reading

Follow Us

RXInjuryHelp.com on Google+  RXInjuryHelp.com on Facebook  RXInjuryHelp.com on LinkedIn  RXInjuryHelp.com on Twitter  RXInjuryHelp.com on YouTube  RXInjuryHelp.com on Pinterest

Skip to content